Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease

Journal of the Neurological Sciences

Volumn 266, Issue 1-2, 2008, Pages 70-78

  Gellein, Kristin ^a   Skogholt, Jon H ^b   Aaseth, Jan ^c   Thoresen, Gunnar B ^c   Lierhagen, Syverin ^a   Steinnes, Eiliv ^a   Syversen, Tore ^a   Flaten, Trond Peder ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Municipality of Sør Odal   (Norway)

^c Sykehuset Innlandet Kongsvinger ^*  (Norway)

Author keywords

Albumin; Copper; CSF proteins; HR ICP MS; Iron; Multiple sclerosis; Skogholt's disease; Zinc

Indexed keywords

COPPER; IRON; TRACE ELEMENT; ZINC;

ADULT; AGED; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHELATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SKOGHOLT DISEASE;

ADULT; BLOOD PROTEIN ELECTROPHORESIS; DEMYELINATING DISEASES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY CONTROL; REFERENCE STANDARDS; SYNDROME; TRACE ELEMENTS;

EID: 38849090668     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.042     Document Type: Article

References (45)

1. Hagen K., Boman H., Mellgren S.I., Lindal S., and Bovim G. Progressive central and peripheral demyelinating disease of adult onset in a Norwegian family. Arch Neurol 55 (1998) 1467-1472
2. Skogholt A. Genetic analysis of a new disease entity: progressive central and peripheral demyelinating disease (M.D. dissertation, in Norwegian). Trondheim: The Norwegian University of Science and Technology, 2006.
3. Zatta P., Lucchini R., van Rensburg S.J., and Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 62 (2003) 15-28
4. Sayre L.M., Perry G., Atwood C.S., and Smith M.A. The role of metals in neurodegenerative diseases. Cell Mol Biol 46 (2000) 731-741
5. Dobson A.W., Erikson K.M., and Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci 1012 (2004) 115-128
6. Perry G., Sayre L.M., Atwood C.S., Castellani R.J., Cash A.D., Rottkamp C.A., et al. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16 (2002) 339-352
7. Aschner M., Silverman W.F., Sekler I., and Zatta P. Metallothioneins in neurodegeneration. In: Zatta P. (Ed). Metal Ions and Neurodegenerative Disorders (2003), World Scientific Publishing, Singapore 307-322
8. Kitzberger R., Madl C., and Ferenci P. Wilson disease. Metab Brain Dis 20 (2005) 295-302
9. Menkes J.H. Menkes disease and Wilson disease: two sides of the same copper coin. Part 1: Menkes disease. Eur J Paediatr Neurol 3 (1999) 147-158
10. Aaseth J., Flaten T.P., and Andersen O. Hereditary iron and copper deposition: diagnostics, pathogenesis and therapeutics. Scand J Gastroenterol 42 (2007) 673-681
11. Barnes P.M., and Moynahan E.J. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerance treated with synthetic diet. Proc R Soc Med 66 (1973) 327-329
12. Strausak D., Mercer J.F.B., Dieter H.H., Stremmel W., and Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull 55 (2001) 175-185
13. Engström E., Stenberg A., Senioukh S., Edelbro R., Baxter D.C., and Rodushkin I. Multi-elemental characterization of soft biological tissues by inductively coupled plasma-sector field mass spectrometry. Anal Chim Acta 521 (2004) 123-135
14. Rodushkin I., Nordlund P., Engström E., and Baxter D.C. Improved multi-elemental analyses by inductively coupled plasma-sector field mass spectrometry through methane addition to the plasma. J Anal At Spectrom 20 (2005) 1250-1255
15. Rodushkin I., Engström E., Stenberg A., and Baxter D.C. Determination of low-abundance elements at ultra-trace levels in urine and serum by inductively coupled plasma-sector field mass spectrometry. Anal Bioanal Chem 380 (2004) 247-257
16. Rodushkin I., and Ödman F. Assessment of the contamination from devices used for sampling and storage of whole blood and serum for element analysis. J Trace Elem Med Biol 15 (2001) 40-45
17. Iyengar V., and Woittiez J. Trace elements in human clinical specimens: evaluation of literature data to identify reference values. Clin Chem 34 (1988) 474-481
18. Sabbioni E., Minoia C., Pietra R., Fortaner S., Gallorini M., and Saltelli A. Trace element reference values in tissues from inhabitants of the European Community. II. Examples of strategy adopted and trace element analysis of blood, lymph nodes and cerebrospinal fluid of Italian subjects. Sci Total Environ 120 (1992) 39-61
19. Bocca B., Alimonti A., Petrucci F., Violante N., Sancesario G., Forte G., et al. Quantification of trace elements by sector field inductively coupled plasma mass spectrometry in urine, serum, blood and cerebrospinal fluid of patients with Parkinson's disease. Spectrochim Acta, Part B: Atom Spectrosc 59 (2004) 559-566
20. Melø T.M., Larsen C., White L.R., Aasly J., Sjøbakk T.E., Flaten T.P., et al. Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis. Biol Trace Elem Res 93 (2003) 1-8
21. Forte G., Visconti A., Santucci S., Ghazaryan A., Figá-Talamanca L., Cannoni S., et al. Quantification of chemical elements in blood of patients affected by multiple sclerosis. Ann Ist Super Sanita 41 (2005) 213-216
22. Moreno M.A., Marin C., Vinagre F., and Ostapczuk P. Trace element levels in whole blood samples from residents of the city Badajoz, Spain. Sci Total Environ 229 (1999) 209-215
23. Rodushkin I., Ödman F., Olofsson R., and Axelsson M.D. Determination of 60 elements in whole blood by sector fields inductively coupled plasma mass spectrometry. J Anal At Spectrom 15 (2000) 937-944
24. Goullé J.-P., Mahieu L., Castermant J., Neveu N., Bonneau L., Lainé G., et al. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair: reference values. Forensic Sci Int 153 (2005) 39-44
25. Heitland P., and Köster H.D. Biomonitoring of 37 trace elements in blood samples from inhabitants of northern Germany by ICP-MS. J Trace Elem Med Biol 20 (2006) 253-262
26. Gasiewicz T.A., and Smith J.C. Properties of the cadmium and selenium complex formed in rat plasma in vivo and in vitro. Chem Biol Interact 23 (1978) 171-183
27. Mauch E., Gebhardt A., Stiefel T., Rauer S., Wagner U., Laufen H., et al. Trace metals in multiple sclerosis. Neurol Psychiatry Brain Res 3 (1995) 149-153
28. Valberg L.S., Flanagan P.R., Kertesz A., and Ebers G.C. Abnormalities in iron metabolism in multiple sclerosis. Can J Neurol Sci 16 (1989) 184-186
29. Dore-Duffy P., Catalanotto F., Donaldson J.O., Ostrom K., and Testa M.A. Zinc in multiple sclerosis. Ann Neurol 14 (1983) 450-454
30. Palavinskas P., and Schulten H.-R. Determination of electrolytes and trace metals in the cerebrospinal fluid of patients with multiple sclerosis and healthy subjects. Trace Elem Med 1 (1984) 29-34
31. Palm R., and Hallmans G. Zinc and copper in multiple sclerosis. J Neurol Neurosurg Psychiatry 45 (1982) 691-698
32. LeVine S.M., Lynch S.G., Ou C.-N., Wulser M.J., Tam E., and Boo N. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 821 (1999) 511-515
33. Smith D.K., Feldman E.B., and Feldman D.S. Trace element status in multiple sclerosis. Am J Clin Nutr 50 (1989) 136-140
34. Rieder H.P., Schoettli G., and Seiler H. Trace elements in whole blood of multiple sclerosis. Eur Neurol 22 (1983) 85-92
35. Exley C., Mamutse G., Korchazhkina O., Pye E., Strekopytov S., Polwart A., et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis. Mult Scler 12 (2006) 533-540
36. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 59 (1992) 1609-1623
37. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 97 (2006) 1634-1658
38. Lin M.T., and Beal F.M. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
39. Dhib-Jalbut S., Arnold D.L., Cleveland D.W., Fisher M., Friedlander R.M., Mouradian M.M., et al. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. J Neuroimmunol 176 (2006) 198-215
40. Smith Q.R., Rabin O., and Chikhale E.G. Delivery of metals to brain and the role of the blood-brain barrier. In: Connor J.R. (Ed) (1997), Plenum Press, New York 113-130
41. Scheuhammer A.M., and Cherian M.G. Binding of manganese in human and rat plasma. Biochim Biophys Acta 840 (1985) 163-169
42. Sickmann A., Dormeyer W., Wortelkamp S., Woitalla D., Kuhn W., and Meyer H.E. Towards a high resolution separation of human cerebrospinal fluid. J Chromatogr B 771 (2002) 167-196
43. Hühmer A.F., Biringer R.G., Amato H., Fonteh A.N., and Harrington M.G. Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Dis Markers 22 (2006) 3-26
44. Valentine H.L., Amarnath K., Amarnath V., and Valentine W.M. Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate. Toxicol Sci 89 (2006) 485-494
45. Bongarzone E.R., Pasquini J.M., and Soto E.F. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res 41 (1995) 213-221